ESTUDIO SUSTANCIAS ANTAGONISTAS PRODUCIDAS POR MICROORGANISMOS
ESTUDIO SUSTANCIAS ANTAGONISTA
![Foto de ESTUDIO SUSTANCIAS ANTAGONISTAS PRODUCIDAS POR MICROORGANISMOS](/img/grupo.png)
![Foto de German Cancer Research Center](/img/noimage_org.png)
German Cancer Research Center
Heidelberg, AlemaniaPublicacions en col·laboració amb investigadors/es de German Cancer Research Center (6)
2022
-
Autophagy in Hematological Malignancies
Cancers, Vol. 14, Núm. 20
2021
-
Polymorphisms within autophagy‐related genes influence the risk of developing colorectal cancer: A meta‐analysis of four large cohorts
Cancers, Vol. 13, Núm. 6, pp. 1-15
-
Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium
Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17
2019
-
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)
Pharmacogenomics Journal
-
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients
Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96
2015
-
Type 2 diabetes-related variantsinfluence the risk of developing multiple myeloma: Results from the IMMEnSE consortium
Endocrine-Related Cancer, Vol. 22, Núm. 4, pp. 545-559